Round, Thomas http://orcid.org/0000-0003-4382-1629
L’Esperance, Veline
Bayly, Joanne
Brain, Kate
Dallas, Lorraine
Edwards, John G.
Haswell, Thomas
Hiley, Crispin
Lovell, Natasha
McAdam, Julia
McCutchan, Grace http://orcid.org/0000-0002-8079-2540
Nair, Arjun
Newsom-Davis, Thomas
Sage, Elizabeth K.
Navani, Neal http://orcid.org/0000-0002-6412-7516
Funding for this research was provided by:
DH | NIHR | Research Trainees Coordinating Centre (DRF-2016-09-054)
Royal Mardsen Partners
RCUK | MRC | Medical Research Foundation (MR/T02481X/1)
Article History
Received: 19 August 2020
Revised: 4 February 2021
Accepted: 11 March 2021
First Online: 10 May 2021
Ethics approval and consent to participate
: No ethical approval was required.
: The rapid review search terms and results are available in Supplementary Materials. All papers and materials are available on request.
: The authors declare no competing interests.
: T.R. is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (DRF) (ref.: DRF-2016-09-054) and was previously supported by a Royal Marsden Partners (RMP) Research Fellowship. T.R. also has an honorary contract with the National Cancer Registration and Analysis Service, Public Health England (PHE). J.B. is supported by the NIHR Applied Research Collaboration South London at King’s College London. V.L. is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (DRF) (ref.: DRF-2017-10-132). N.N. is supported by an MRC Clinical Academic Research Partnership (MR/T02481X/1). This work was partly undertaken at UCLH/UCL who received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme. T.R. and N.N. are collaborators on a Cancer Research UK (CRUK) Early Diagnosis Advisory Group (EDAG) project award (ref.: C11558/A25623); ‘Identifying missed actionable events in the natural history of lung cancer prior to diagnosis in primary care and implementing them in a learning health system in NE London’. T.R., N.N. and K.B. collaborated on a COVID-19 and lung cancer educational webinar funded by Astra Zeneca, but with no editorial input from the funder. The views expressed are those of the authors and not necessarily those of their institutions or funders, including MRC, NIHR, NHS, RMP, Public Health England (PHE) or the Department of Health and Social Care.
Free to read: This content has been made available to all.